Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Buprenorphine blocks diffuse noxious inhibitory controls in the rat

F Guirimand1, M Chauvin, J C Willer

  • 1INSERUM U 161, Paris, France.

European Journal of Pharmacology
|December 29, 1995
PubMed
Summary

Buprenorphine modulates diffuse noxious inhibitory controls in rats. Low doses enhance pain inhibition, while higher doses block it, revealing mechanisms behind buprenorphine

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell-Wall-Associated Proteinases in Lactobacillus casei and Lactobacillus plantarum.

Journal of food protection·2019
Same author

Bleeding risk of terminally ill patients hospitalized in palliative care units: the RHESO study.

Journal of thrombosis and haemostasis : JTH·2016
Same author

PET radiotracers for molecular imaging of serotonin 5-HT1A receptors.

Current medicinal chemistry·2013
Same author

Mechanical allodynia in neuropathic pain. Where are the brain representations located? A positron emission tomography (PET) study.

European journal of pain (London, England)·2013
Same author

Motor neuron disorders: novel electrophysiologic approach (MUFDEC protocol).

Supplements to Clinical neurophysiology·2010
Same author

Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study.

Pain·2009

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • Diffuse noxious inhibitory controls (DNIC) are endogenous pain-modulating pathways.
  • Understanding DNIC mechanisms is crucial for developing effective analgesics.
  • Opioids, like buprenorphine, are known to interact with pain pathways.

Purpose of the Study:

  • To investigate the effect of buprenorphine on DNIC in an animal model.
  • To elucidate the role of buprenorphine in modulating pain inhibition.

Main Methods:

  • Electrically stimulated C-fibre reflex recorded from biceps femoris muscle in anesthetized rats.
  • DNIC elicited by noxious heat conditioning stimulus applied to the tail (50°C for 1 min).
  • Administration of varying doses of buprenorphine (0.3–3 μg/kg) to assess its modulatory effects.

Related Experiment Videos

Main Results:

  • Noxious heat stimulation of the tail significantly depressed C-fibre reflex responses (up to 71%).
  • Buprenorphine (0.3–3 μg/kg) dose-dependently enhanced this DNIC-mediated inhibition.
  • A higher dose (3 μg/kg) of buprenorphine completely blocked DNIC and associated post-stimulus effects.

Conclusions:

  • Buprenorphine modulates DNIC in a dose-dependent manner, enhancing pain inhibition at lower doses.
  • The findings suggest buprenorphine's analgesic effects involve potentiation of endogenous pain control mechanisms.
  • These results provide insights into the neurobiological underpinnings of buprenorphine's pain-relieving properties.